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Abstract
Background: The Copper Metabolism MURR1 Domain containing 1 protein COMMD1 has been associated with copper
homeostasis, NF-kB signaling, and sodium transport. Recently, we identified COMMD1 as a novel protein in HIF-1 signaling.
Mouse embryos deficient for Commd1 have increased expression of hypoxia/HIF-regulated genes i.e. VEGF, PGK and Bnip3.
Hypoxia-inducible factors (HIFs) are master regulators of oxygen homeostasis, which control angiogenesis, erythropoiesis,
glycolysis and cell survival/proliferation under normal and pathologic conditions. Although HIF activity is mainly controlled
by ubiquitination and protein degradation by the von Hippel Lindau (pVHL) tumor suppressor gene other mechanisms have
recently been identified that regulate HIF signaling independently of pVHL.
Principal Findings: Here we characterized the mechanism by which COMMD1 regulates HIF-1a protein degradation. We
show that COMMD1 competes with the chaperone heat shock protein HSP90b for binding to the NH2-terminal DNA-
binding and heterodimerization domain of HIF-1a to regulate HIF-1a stability together with HSP70. Inhibition of HSP90
activity with 17-Allylamino-17-demethoxygeldanamycin (17-AAG) increased COMMD1-mediated HIF-1a degradation
independent of ubiquitin and pVHL.
Conclusion/Significance: These data reveal a novel role for COMMD1 in conjunction with HSP90b/HSP70 in the ubiquitin
and O2-independent regulation of HIF-1a.
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Introduction
Copper Metabolism MURR1 Domain 1 protein (COMMD1) is
the prototype of the COMMD protein family [1]. This family of
proteins is highly conserved between eukaryotes, and some
members have been identified in protozoa [1,2]. The COMM
proteins are ubiquitously expressed and characterized by their
conserved and distinctive domain (COMM domain) located at the
carboxy-terminus. The COMMD domain is important for
protein-protein interactions, nuclear export and postranslational
modifications of COMMD proteins [3–5].
To date the best-characterized COMMD protein is COMMD1.
We identified COMMD1 (previous called MURR1) to be mutated
in dogs with the hepatic copper storage disorder, copper toxicosis
[6,7]. Recent observations suggest that COMMD1 regulates the
biliary copper excretion via ATP7B, a P-type ATPase copper
transporter that is mutated in patients with the copper storage
disorder Wilson’s disease [8,9]. It appears that COMMD1
participates in the protein quality control of ATP7B by mediating
the proteolysis of ATP7B [8].
COMMD1 also inhibits basal and cytokine induced NF-kB
activity by promoting the ubiquitination and proteasomal
degradation of RelA [1,5,10]. To understand the in vivo role of
COMMD1 we generated Commd1 deficient mice [11]. Remark-
ably, Commd1 knockout mice are embryonically lethal, and show
abnormal embryonic development, including placental defects.
Gene expression analysis in Commd1 deficient embryos revealed
deregulation of the hypoxia inducible factor (HIF) pathway by
upregulation of canonical HIF-1 target genes like Vegfa, Pgk1,
AldoA, Bnip3 and others. Conversely, overexpression of COMMD1
resulted in downregulation of HIF-1 activity [11].
HIF-1 is a key factor in oxygen homeostasis. Under conditions
of chronic or acute oxygen deprivation (hypoxia), HIF-1 regulates
the transcriptional activation of target genes involved in
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ation [12]. HIF-1a is a basic-helix-loop-helix (bHLH)-PAS (Per,
ARNT, SIM) protein and forms together with HIF-1b the
transcription factor HIF-1 [13]. The N-terminal bHLH and
PAS domain of HIF-1a and HIF-1b mediates heterodimerization
and DNA binding [14]. The cellular HIF-1a protein level is tightly
regulated by oxygen. During normoxia HIF-1a is continuously
hydroxylated by prolyl hydroxylases (PHD1-3), which, in turn
recruits the VCB-Cul2 (von Hippel-Lindau protein (pVHL),
Elongin B/C, Cullin2) E3 ubiquitin ligase complex [15–18].
VCB-Cul2 ubiquitinates HIF-1a and thereby targets it for 26S
proteasomal degradation. HIF-1a is hydroxylated at conserved
proline residues (402 and 564) located within the oxygen-
dependent degradation domain (ODDD). Under hypoxic condi-
tions, hydroxylase activities of PHDs are attenuated, resulting in
HIF-1a stabilization and eventually the formation of active HIF-1
that regulate gene expression of HIF-1 target genes by binding to
hypoxia responsive elements (HREs) [14,19].
Although HIF-1 is generally regulated by pVHL, it has become
apparent that more pathways are involved in the regulation of
basal HIF-1a levels in an oxygen- and pVHL-independent
manner (reviewed in [20,21]). Recent studies showed that the
heatshock protein 90b (HSP90b) binds HIF-1a and is necessary
for proper maturation and stabilization of HIF-1a under normoxic
and hypoxic conditions. HSP90b is a molecular chaperone that is
involved in many different cellular processes and contributes to
post-translation maturation and folding of client proteins (reviewed
by [22]). HSP90 inhibitors, e.g. geldanamycin or 17-Allylamino-
17-demethoxygeldanamycin (17-AAG), both induce ubiquitin-
independent and ubiquitin-dependent degradation of HIF-a
independent of pVHL [23–28].
In this study, we further characterized the role of COMMD1 in
HIF-1a proteolysis and demonstrated that COMMD1 regulates
HIF-1a stability in a pVHL/O2 and ubiquitin-independent
manner by competing with HSP90b for binding to HIF-1a. Our
findings suggest that COMMD1 is associated with the HSP90b/
HSP70 chaperone regulatory axis in regulating HIF-1 pathway
activity, and explain why loss of COMMD1 attenuates HIF-1a
proteolysis in vivo.
Results
COMMD1 mediates HIF-1a protein stability
We previously demonstrated that COMMD1 physically inter-
acts with HIF-1a and that loss of COMMD1 is associated with
increased HIF-1a protein stability in vivo and in vitro. To further
define the role of COMMD1 in HIF-1a regulation, we generated
stable HeLa COMMD1 knock down cells by transfection of
pSuper–shRNA, as described previously [11]. This cell line and a
control HeLa cell line were cultured for 18 h at 1% O2, which
resulted in comparable HIF-1a protein stabilization in both cell
lines (Figure 1A). Upon reoxygenation (ambient O2), HIF-1a levels
decreased in both cell lines but in COMMD1 knockdown cells the
rate of HIF-1a degradation was markedly reduced. After 5 min of
normoxic exposure, high HIF-1a level was still seen in COMMD1
knockdown cells, whereas HIF-1a was almost undetectable in the
control cell line. In both cells lines, higher molecular weight species
of HIF-1a were detected by immunoblotting that appeared more
abundant in reoxygenated COMMD1-silenced cells. The identity
of these higher molecular weight band is unknown at present but
may represent posttranslational modification such as ubiquitina-
tion. These findings are in agreement with a role for COMMD1 in
HIF-1a degradation as observed in HEK 293T cells [11]
Recently we suggested that COMMD1 promotes the proteolysis
of newly synthesized and incorrectly folded ATP7B proteins [8].
To investigate whether COMMD1 is also involved in the stability
of newly synthesized HIF-1a, we studied the dynamics of HIF-1a
maturation at several time-points after oxygen deprivation in
control or COMMD1 knockdown cells. These cells, cultured
under normoxia (21% O2), were exposed to hypoxia (1% O2) after
removal of the culture medium to obtain rapid deoxygenation.
Upon oxygen deprivation, the levels of HIF-1a rapidly increased
in both cell lines in a time-dependent fashion (Figure 1B).
However, HIF-1a level in COMMD1 silenced cells were markedly
Figure 1. COMMD1 mediates HIF-1a protein stability. (A) The stability of HIF-1a protein was determined in HeLa COMMD1 knockdown (KD) and
control (EV) cells by immunoblotting. After hypoxia (1% O2) for 8 hours the cells were reoxygenized (21% O2) for the indicated time prior to cell lysis.
Post-translational modified HIF-1a, can be seen as high-molecular mass-proteins detected by anti-HIF-1a antibody indicated with asterisks. b-actin
expression was used as a loading. (B) The maturation/stability of HIF-1a protein, was determined in HeLa COMMD1 knockdown (KD) and control cells
(EV) by immunoblotting. After culturing the cells under normoxic conditions (21% O2) cells were exposed to 1% O2 for the indicated times. HSP90b
expression was determined and b-actin expression was used as a loading control. This experiment was repeated three times with similar results.
doi:10.1371/journal.pone.0007332.g001
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results were obtained with silenced COMMD1 HEK 293T cells
(data not shown). Altogether, these data indicate that COMMD1
controls the protein degradation and maturation of HIF-1a.
COMMD1 competes with HSP90b for binding to HIF-1a
We recently showed that COMMD1 directly binds to the N-
terminal region of HIF-1a and competes with HIF-1b for binding
to HIF-1a (van de Sluis et al., submitted). The heat shock protein
HSP90b binds also to this region of HIF-1a and is essential for the
stability and maturation of HIF-1a protein [25]. Since both
proteins bind to same region, we examined the interaction
between HIF-1a and COMMD1 in relation to HSP90b levels.
COMMD1-Ha and Flag-HIF-1a were transfected in HEK 293T
cells in the presence of increasing amounts of Ha-HSP90b.
COMMD1-Ha co-immunoprecipitated with HIF-1a under all
conditions, but the level of COMMD1-HIF-1a binding gradually
decreased with increasing HSP90b levels (Figure 2A). The
competition between HSP90b and COMMD1 for HIF binding
could be reversed when culturing in the presence of an HSP90
specific inhibitor, 17-Allylamino-17-demethoxygeldanamycin (17-
AAG). Moreover, the interaction between COMMD1 and HIF-
1a was enhanced after 17-AAG treatment compared to mock
treated cells or cells not transfected with HSP90b. This interaction
was even more pronounced when proteasomal degradation was
blocked (Figure 2B). Consistent with a competition model, we
Figure 2. HSP90b competes with COMMD1 for binding to HIF-1a. (A). HEK 293T cells were transfected with cDNA constructs encoding
COMMD1-Ha, Flag-HIF-1a, or Ha-HSP90b with increase amounts of plasmid DNA as indicated. Whole cell lysates were immunoprecipitated with anti-
Flag antibody and subjected to Western Blot analysis. (B) Anti-Flag immunprecipitations using HEK 293T whole cells lysates expressing Ha-HSP90b,
COMMD1-Ha, Flag-HIF-1a. Prior to cell lysis and immunoprecipitation cells were treated with vehicle, 17-AAG (2 mM, 8 hr), or MG132 (5 mM, 8 hr) as
indicated. (C) Cells were cotransfected with Ha-HSP90b, COMMD1-Ha, Flag-HIF-1a. Whole cell lysates were subjected to immunprecipation with anti-
Flag antibody. Bands were quantified by densitometry using Quantity One (Bio-Rad) to calculate the quantity of the ratio of precipitated HSP90b
relative to the input levels. The percentage of precipitated HSP90b is indicated (D) HEK 293T whole cells lysates expressing Ha-HSP90b, COMMD1-Ha,
Flag-HIF-1a (P402A/P564A) were used for immunprecipation with anti-Flag antibody. Prior to cell lysis and immunoprecipitation cells were treated
with vehicle or 17-AAG (2 mM, 8 hr). All data represent at least two experiments with comparable results.
doi:10.1371/journal.pone.0007332.g002
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binding to HIF-1a (Figure 2C). To address whether COMMD1/
HSP90 mediated HIF-1a degradation was dependent on pVHL
we used a hydroxy-prolyl HIF-1a mutant (P402A/P564A), which
is not targeted for pVHL-mediated proteasomal degradation.
HSP90b also decreased the binding of COMMD1 with the
hydroxy-prolyl HIF-1a mutant and was completely abrogated in
the presence of 17-AAG (Figure 2D) indicating that the effect of
COMMD1 was independent of proly-hydroxylation and pVHL
binding to HIF-1a. These results show that the binding of
COMMD1 to HIF-1a is in competition with active HSP90b,i na
dose-dependent manner.
COMMD1 promotes HIF-1a degradation in an ubiquitin
independent manner
Since HSP90b regulates the HIF-1a protein stability in a
pVHL-independent manner we investigated the stability of the
hydroxy-prolyl HIF-1a mutant (P402A/P564A) in HEK 293T
cells stably overexpressing COMMD1-Flag (Figure 3A). HEK-
293T-COMMD1 cells expressed approximately 3.5-fold higher
Figure 3. COMMD1 increased HIF-1a proteolysis in an HSP90-dependent but ubiquitin independent manner. HEK 293T stably
overexpressing COMMD1-Flag (OV) and control cells (EV) (A) were transfected with Flag-HIF-1a (P402A/P564A). Cells were untreated or treated with
17-AAG (2 mM) and CHX (40 mg/ml) was added to the cells. HIF-1a levels were determined by Western Blot analysis. Bands were quantified by
densitometry using Quantity One (Bio-Rad) to calculate the half-life values (T1/2) of HIF-1a (P402A/P564A). For each sample, mean values6SEM are
shown (n=3), significant difference were determined using a Student t-test, p=0.0438 (C) Ts20 cells, containing thermolabile ubiquitin activation
enzyme E1, were transfected with empty vector or COMMD1-flag. Cells were cultured under permissive temperature (30uC) or nonpermissive
temperature (39uC) for 10 hr. Cells were treated with vehicle or 17-AAG for 8 hr prior to cell lysis and western blot analysis. All data represent three
experiments with comparable results.
doi:10.1371/journal.pone.0007332.g003
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protein was repressed in HEK293-COMMD1-Flag cells
(Figure 3A), a phenomenon also observed and described by others
[3]. We expressed Flag-HIF-1a (P402A/P564A) in both cell lines
in the presence or absence of 17-AAG. After adding cyclohex-
amide (CHX), to block new protein synthesis, we assessed whether
COMMD1 overexpression resulted in a decrease of HIF-1a
stability. No clear difference in HIF-1a stability could be detected
between COMMD1 overexpression and control HEK 293T cells
in the absence of 17-AAG, whereas the half-life of HIF-1a was
markedly reduced in control cells and COMMD1 overexpression
cells treated with 17-AAG (Figure 3B). However, inhibition of
HSP90b in COMMD1 overexpressing cells significantly decreased
the half-life of HIF-1a compared to control cells (Figure 3B). Next,
we studied whether COMMD1 promotes the degradation of HIF-
1a in an ubiquitin-independent manner by studying the expression
of endogenous HIF-1a in a Chinese hamster ovary (CHO) cell line
(Ts20), which contains thermolabile ubiquitin activation enzyme
E1 [29]. At non-permissive temperature (39uC) the ubiquitin
conjugation is dysfunctional and leads to HIF-1a stability in an
oxygen-independent manner (Figure 3C). Under these conditions
HIF-1a levels were clearly reduced when HSP90b activity was
inhibited. Interestingly, overexpression of COMMD1 together
with 17-AAG treatment considerably decreased endogenous HIF-
1a levels in the absence of ubiquitination (Figure 3C). These data
further demonstrate that COMMD1 mediates HIF-1a stability in
concert with HSP90b activity in a manner independent pVHL-
mediated polyubiquitination.
COMMD1 forms a tripartite complex with HSP70 and HIF-
1a
Heat shock protein HSP70 also binds to HIF-1a in an HSP90b-
dependent manner and facilitates the proteolysis of misfolded and
immature HIF-1a [25] in a manner similar seen for COMMD1
(Figure 2B,D). We therefore hypothesized that COMMD1 may
act as a ‘scaffold’ protein involved degradation of HIF-1a together
with HSP70. First we studied the interaction between HSP70 and
HIF-1a under normal conditions and after attenuating HSP90
activity. Blocking HSP90 clearly increased the binding between
HSP70 and HIF-1a (Figure 4A). Second, we investigated whether
HSP70 and COMMD1 form a protein complex with HIF-1a.T o
address this we sequentially precipitated Flag-HIF-1a from cells, in
which we co-expressed Flag-HIF-1a, HSP70 and COMMD1-Ha.
Transfected cells were treated with 17-AAG to block HSP90b
activity prior to cell lysis. Flag-precipitates were eluted with Flag-
peptide and subsequently re-precipitated with anti-Ha to enrich
for COMMD1 containing immunocomplexes. As demonstrated in
Figure 4B, HSP70 could be found in complex with COMMD1 in
cells expressing HIF-1a. To delineate whether COMMD1 is
associated with HSP70, HSP70 was immunoprecipitated from
HEK 293T cell lysates expressing HSP70-V5 and COMMD1-Ha.
COMMD1 was clearly present in HSP70-immunoprecipates
(Figure 4C). These data indicate that COMMD1 can form with
HSP70 a tripartite complex with HIF-1a.
Discussion
COMMD1 has been recognized as a protein that plays an
important role in wide range of biological processes, including
copper metabolism, NF-kB signaling and sodium transport
(reviewed in [21]). We recently identified COMMD1 as a novel
protein regulating HIF-1 signaling as embryos deficient for
Commd1 display upregulation of HIF-1 target genes with
corresponding increased HIF-1a protein stability [11]. In this
study, we further characterized the mechanism of COMMD1 in
HIF-1a regulation and demonstrated that COMMD1 competes
with HSP90b for binding to HIF-1a to facilitate HIF-1a
degradation. Overexpression of COMMD1 enhances the protein
degradation of HIF-1a in an HSP90-dependent but pVHL/O2
and ubiquitin-independent manner (Figure 3). Previous studies
reported that upon HSP90 inhibition, a protein complex
consisting of HSP70 and HIF-1a is formed to facilitate 20S
proteasomal degradation in an ubiquitin-independent fashion
[25,30,31]. Here we showed that COMMD1 is in complex with
HSP70/HIF-1a suggesting that COMMD1 acts in concert with
HSP70 to facilitate proteolysis of HIF-1a in an HSP90-dependent
manner.
The effect of COMMD1 on HIF-1a stability is also evident
during the early transitions between hypoxia and normoxia and
vice versa. In cells reoxygenation in the absence COMMD1 results
in a delay in the rate of HIF-1a degradation (Figure 1A). It is well
established that under normal oxygen conditions, HIF-1a levels
are downregulated by polyubiquitination and proteosomal degra-
dation (18). We therefore hypothesize that the higher molecular
weight protein, detected by the HIF-1a antibody, represents
polyubiquitinated-HIF-1a species. We have previously observed
the same HIF-1a pattern in HEK 293T COMMD1 deficient cells
upon reoxygenation ([11]). The persistence of polyubiquitinated
HIF-1a in COMMD1 deficient cells may suggest that COMMD1
does not affect HIF-1a polyubiquitination per se but assists the
proteasomal degradation of HIF-1a. This could also explain why
HIF-1 transcriptional activity is higher in the absence of
COMMD1 (11). Together with our observation that COMMD1
interacts with the 20S proteasome (supplemental Figure S1) we
hypothesize that COMMD1 may escort HIF-1a protein to the
proteasome. Furthermore, the increased interaction between
COMMD1 and 20S after blocking proteasomal degradation,
supports a more general role for COMMD1 in the 20S
proteasome. Ubiquitin-independent degradation of HIF-1a di-
rectly by the 20S proteosome has also been reported by others and
seems to be involved in regulating constitutive degradation of HIF-
1a during hypoxia [31]. While HIF-1a can interact with the 20S
proteasome subunit PMSA7 (a-4 subunit), it is unknown yet
whether this is a direct process or regulated by other proteins [32].
Although more studies are needed, these data shed light on a novel
pathway of HIF-1a regulation by the 20S proteasome in an O2
and ubiquitin-independent manner.
A competition with HSP90b for binding to HIF-1a was also
reported for Receptor for activated protein kinase C 1
(RACK1) [26]. Similar as for COMMD1, RACK1 reduces
HIF-1 transcriptional activity and mediates HIF-1a protein
degradation independent of O2-and pVHL. However, in
c o n s t r a s tt oC O M M D 1 ,R A C K 1r e c r u i t st h eE l o n g i n - C / B
ubiquitin ligase complex and regulates HIF-1a stability in an
ubiquitin-dependent fashion. Importantly, we found no effect
of COMMD1 on RACK1-HIF-1a binding (supplemental
Figure S2) suggesting that COMMD1 does not compete with
RACK1 for binding to HIF-1a and regulates HIF in a distinct
manner.
Interestingly, COMMD1 also promotes the proteolysis of the
copper transporting p-type ATPase ATP7B [8]. This study
established a stronger binding between COMMD1 and ATP7B
mutants that are associated with mis-localization and protein
instability compared to wild-type ATP7B. It has been postulat-
ed that COMMD1 is engaged in the quality control and protein
folding of newly synthesized ATP7B. Although recent data
demonstrated interaction between ATP7B and the molecular
chaperones HSP70 and HSP90b (unpublished data, P. van den
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regulating ATP7B degradation is largely unknown. Further
studies are needed to reveal whether COMMD1 also cooperates
with HSP70 and HSP90b to regulate the structural integrity
of ATP7B by assisting the proteolysis of misfolded ATP7B
proteins
Taken together, this study demonstrates that COMMD1, in
complex with HSP70, facilitates the proteasomal degradation of
HIF-1a in an HSP90-dependent and ubiquitin independent
manner (Figure 5). In addition, these findings highlight a
potentially novel role of COMMD1 protein in escorting client
proteins to the proteasome. Importantly, hypoxia is a hallmark of
solid cancers and HIF-1 activity correlates with a poor prognosis in
many cancers [33,34]. Currently, HSP90 inhibitiors (e.g. 17-AAG)
are being tested in clinical trials as potential anti-cancer agents
[35]. Therefore, further elucidation of the molecular mechanism
of HSP90-dependent proteolysis of proteins may reveal additional
opportunities for modulation of HIF-1 activity in human disease,
including cancer.
Materials and Methods
Construction of expression constructs
Flag-HIF-1a construct was previously described [11]. Mutants
for full length HIF-1a P402A/P564A were generated using the
QuickChangeH XL Site directed Mutagenesis Kit (Stratagene, La
Jolla, CA, USA) according to the manufacturer’s protocol, using the
primers P402A forward 59-CTTTAACTTTGCTGGCCG-
CAGCCGCTGGAGACAC-39 and P402A reverse 59-GTGTC-
TCCAGCGGCTGCGGCCAGCAAAGTTAAAG-39 and P564A
forward 59-CTTGGAGATGTTAGCTGCCTATATCCCAAT-
GGATG-39 and P564A reverse 5-CATCCATTGGGATATAGG-
CAGCTAACATCTCCAAG-39. pcDNA3.1-Ha-HSP90b was
kindly provided by Dr. D. Manor (Case Western Reserve
University, Cleveland, OH, USA), pcDNA3.1-HSP70 and
pcDNA5/FRT/TO-HSP70-V5 was kindly provided by Dr. H.
Kampinga (Department of Cell Biology, UMC Groningen, the
Netherlands). A plasmid containing the RACK1 cDNA was kindly
provided by Dr. D. Qian and recloned in p3xFLAG-CMV10.
Figure 4. COMMD1 forms a tripartite complex with HSP70 and HIF-1a. (A) HEK 293T whole cells lysates expressing HSP70 and Flag-HIF-1a
were used for anti-Flag immunprecipitation. Prior to cell lysis cells were treated with vehicle or 17-AAG (2 mM, 8 hr) as indicated. (B) HEK 293T cells
were transfected with plasmids encoding HSP70, COMMD1-Ha and Flag-HIF-1a. Lysates of cells, which were treated with 17-AAG (2 mM, 8 hr), were
used for sequential immunoprecipitation. Anti-Flag precipitates were eluted with Flag-peptides and eluates were used for immunoprecipitation with
anti-HA antibody. Whole cell lysates, and immunoprecipitates were subjected to Western Blot analysis. (C) Using anti-V5 antibody HSP70 was
immunoprecipitated from HEK 293T cell lystates expressing HSP70-V5 and COMMD1-Ha. Whole cell lysates, and precipitates were analyzed by SDS-
PAGE and immunoblotting as indicated.
doi:10.1371/journal.pone.0007332.g004
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immunoblotting
HEK 293T and HeLa cells were cultured in Dulbecco’s
modified Eagle medium supplemented with 10% fetal bovine
serum, penicillin-streptomycin, L-glutamine. Cells were cultured
at 5% CO2, 21% O2 for normoxia and 1% O2 for hypoxia in an
Invivo2 Hypoxia Workstation 1000 (Biotrace International, UK) at
37uC. Stable HeLa COMMD1 knockdown cells were generated as
previously described [11]. Monoclonal were selected by culturing
on a medium supplemented with 1 mg/ml puromycin (Sigma-
Aldrich, Zwijndrecht, the Netherlands). Ts20 cells were cultured
in MEM Alpha medium+GlutaMAX, supplemented with 10%
fetal bovine serum, penicillin-streptomycin. Ts20 cells were
cultured at 5% CO2, 21% O2 at 30uC.
Linear polyethylenimine (P-PEI, Polysciences Inc, Warrington,
PA, USA) was used for tranfections. After transfection, cells were
lysed in lysis buffer (0.4 M NaCl, 0.1% NP-40, 10 mM Tris-HCl
(pH 8.0), 1 mM EDTA) supplemented with 1 mM Na3VO4,
protease inhibitors (Roche, Basle, Switzerland), and 10 mM
dithiothreitol. In several experiments MG132 (5 mM, 8 hr) was
used to prevent proteasomal degradation of HIF-1a and to attain
constant HIF-1a levels. HSP70-V5 expression was achieved by
adding doxycycline after transfection. Cell line extracts represent-
ing 30 mg protein were transferred onto Hybond-P membranes
as explained previously [11]. Immunoblots were probed with
anti-COMMD1 antiserum (1:5,000) [6], anti-Flag (F1804;
Sigma-Aldrich), anti-Ha (clone HA-7, Sigma-Aldrich), anti-b-actin
monoclonal antibodies (clone AC-74; Sigma-Aldrich), anti-HIF-1
a (clone 54; BD Bioscience, Alphen aan de Rijn, the Netherlands),
anti-HSP70 (sc-1060, Santa Cruz), anti-HSP90b (SPA-843,
Stressgen, Victoria, British Columbia, Canada).
Supporting Information
Figure S1 COMMD1 interacts with 20S proteasome. Glutathi-
one-sepharose precipitations using cell lysates of HEK 293T
transfected with GST or COMMD1-GST. Prior cell lysis, cells
were untreated (mock treated, DMSO) or treated with MG132
(5 mM, 8 hr) as indicated. Proteins were detected with anti-GST or
anti-20S a-subunit (a1, 2 ,3 ,5 ,6 & 7, Biomol, clone MCP231) as
indicated. Input designates direct analysis of cell lysates.
Found at: doi:10.1371/journal.pone.0007332.s001 (0.34 MB
PDF)
Figure S2 COMMD1 does not compete with RACK1 for
binding to the N-terminus of HIF-1a. Glutathione-sepharose
precipitations using cell lysates of HEK 293T transfected with
GST or GST-HIF-1a (1–300), RACK1-Flag or COMMD1-Ha
with increased amounts of plasmid as indicated. Precipitates were
washed and separated by SDS-PAGE and immunoblotted as
indicated. Input designates direct analysis of cell lysates.
Found at: doi:10.1371/journal.pone.0007332.s002 (5.03 MB
PDF)
Figure 5. Schematic representation of the mechanism of COMMD1-associated HIF-1a degradation. Under normoxic conditions, newly
synthesized HIF-1a binds to HSP70 and HSP90 for proper maturation, but it is immediately degraded by the 26S proteasome after it is hydroxylated
and ubiquitinated in a pVHL dependent process. Under hypoxic conditions, HIF-1a is not subjected to hydroxyl- and ubiquitin-dependent
degradation and heterodimerizes with HIF-1b, and binds to hypoxia response element (HRE) containing promoters in target genes. Upon
reoxygenation HIF-1a is ubiquitinated by pVHL, and COMMD1 is bound to HIF-1a to facilitate proteasomal degradation. Inactivation of HSP90 (e.g.
using 17-AAG or Geldanamycin) leads to incorrect folding of HIF-1a and the formation of a heterocomplex with HSP70 and COMMD1, and
subsequently degradation by the 20S proteasome. Altogether, in this study we suggest that COMMD1 facilitates the proteasomal degradation of HIF-
1a after reoxygenation or HSP90 inhibition independent of posttranslational modification by ubiquitin.
doi:10.1371/journal.pone.0007332.g005
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